Vimarsana
Biggest News Aggregation in the World

Page 2 - Daniel Getts News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Daniel Getts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Daniel Getts Today - Breaking & Trending Today

Myeloid Therapeutics Presents Late-Breaking Data on Multiple Platforms at the American Association for Cancer Research (AACR) 2023 Annual Meeting - Vimarsana News

Myeloid Therapeutics Presents Late-Breaking Data on Multiple Platforms at the American Association for Cancer Research (AACR) 2023 Annual Meeting

/PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage mRNA-immunotherapy company, today announced its presentation of two posters at the...

Creating a genetic medicine manufacturing ecosystem: part 4 - Vimarsana News

Creating a genetic medicine manufacturing ecosystem: part 4

We are on the precipice of an explosion in local manufacturing of genetic medicines on a scale never seen before, with global equitable access.

Myeloid Therapeutics to Present at the Guggenheim Healthcare Talks 2023 Oncology Day - Vimarsana News

Myeloid Therapeutics to Present at the Guggenheim Healthcare Talks 2023 Oncology Day

/PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage mRNA-immunotherapy company, today announced that management will present at the...

Myeloid Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference - Vimarsana News

Myeloid Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

/PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage mRNA-immunotherapy company, today announced that Daniel Getts, Ph.D., CEO of Myeloid,...

Myeloid Therapeutics Strengthens Senior Team to Support the Expansion of its Manufacturing Capabilities - Vimarsana News

Myeloid Therapeutics Strengthens Senior Team to Support the Expansion of its Manufacturing Capabilities

/PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage mRNA-immunotherapy company harnessing the power of myeloid and innate biology to...